Long-acting insulin analogue in the treatment of type 2 diabetes mellitus: emphasis on proven efficacy and safety
In time, prescription of insulin therapy (IT) becomes inevitable for many patients with type 2 diabetes mellitus (DM) to achieve and maintain the target hypoglycemic range.According to the current guidelines, the addition of basal insulin to glucose-lowering therapy in patients with insufficient con...
Main Authors: | E. V. Biryukova, M. V. Shinkin, O. M. Mikheeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2021-09-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/6355 |
Similar Items
-
ATOS study: effectiveness and safety of insulin glargine 300 U/mL in the real world clinical practice in insulin-naïve type 2 diabetic patients in the Russian Federation
by: Gagik R. Galstyan
Published: (2022-10-01) -
rDNA insulin glargine U300 – a critical appraisal
by: Wang F, et al.
Published: (2016-12-01) -
Clinical experience in using long-acting human insulin Glargine 300 U/ml in the practice of an endocrinologist
by: O. A. Guseva, et al.
Published: (2018-04-01) -
Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross‐over study
by: Mizuho Yamabe, et al.
Published: (2019-03-01) -
A review of reusable insulin pens and features of TouStar—a new reusable pen with a dedicated cartridge
by: Robert Veasey, et al.
Published: (2021-12-01)